Xebio Holdings Co., Ltd. (TYO:8281)
1,092.00
-1.00 (-0.09%)
Oct 15, 2026, 3:30 PM JST
Xebio Holdings Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 45,189 | 41,051 | 54,466 | 43,769 | 46,377 | 41,868 | |
Market Cap Growth | -1.27% | -24.63% | 24.44% | -5.63% | 10.77% | 1.18% |
Enterprise Value | 35,096 | 33,660 | 39,562 | 30,522 | 23,671 | 21,097 |
Last Close Price | 1093.00 | 976.61 | 1233.89 | 920.31 | 946.61 | 828.84 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 123.25 | - | 56.09 | 16.89 | 8.59 | 10.91 |
Forward PE | - | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 |
PS Ratio | 0.18 | 0.16 | 0.22 | 0.18 | 0.19 | 0.19 |
PB Ratio | 0.38 | 0.35 | 0.45 | 0.35 | 0.38 | 0.35 |
P/TBV Ratio | 0.41 | 0.38 | 0.48 | 0.38 | 0.40 | 0.37 |
P/FCF Ratio | 19.46 | 17.66 | 10.18 | - | 12.66 | - |
P/OCF Ratio | 4.67 | 4.24 | 4.52 | 10.24 | 6.61 | 18.73 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.14 | 0.13 | 0.16 | 0.13 | 0.10 | 0.09 |
EV/EBITDA Ratio | 3.26 | 3.60 | 3.06 | 3.28 | 1.91 | 2.28 |
EV/EBIT Ratio | 9.87 | 14.20 | 5.65 | 7.26 | 2.84 | 4.22 |
EV/FCF Ratio | 15.12 | 14.48 | 7.40 | - | 6.46 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.10 | 0.05 | 0.06 | 0.08 | 0.10 | 0.13 |
Debt / EBITDA Ratio | 1.13 | 0.67 | 0.57 | 1.07 | 1.02 | 1.64 |
Debt / FCF Ratio | - | 2.71 | 1.38 | - | 3.45 | - |
Net Debt / Equity Ratio | -0.09 | -0.08 | -0.10 | -0.12 | -0.16 | -0.21 |
Net Debt / EBITDA Ratio | -0.95 | -1.02 | -0.96 | -1.61 | -1.63 | -2.67 |
Net Debt / FCF Ratio | - | -4.10 | -2.33 | 293.88 | -5.53 | 19.22 |
Asset Turnover | 1.21 | 1.23 | 1.21 | 1.15 | 1.14 | 1.07 |
Inventory Turnover | 1.80 | 1.86 | 1.86 | 1.83 | 1.88 | 1.85 |
Quick Ratio | 0.49 | 0.45 | 0.61 | 0.68 | 0.79 | 0.84 |
Current Ratio | 1.80 | 1.83 | 1.96 | 1.98 | 2.02 | 1.97 |
Return on Equity (ROE) | 0.10% | -2.02% | 0.79% | 2.21% | 4.64% | 3.28% |
Return on Assets (ROA) | 1.05% | 0.72% | 2.12% | 1.25% | 2.48% | 1.50% |
Return on Invested Capital (ROIC) | 0.35% | 2.17% | 2.03% | 2.40% | 5.37% | 3.42% |
Return on Capital Employed (ROCE) | 2.60% | 1.80% | 5.10% | 3.00% | 6.00% | 3.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.81% | -5.27% | 1.78% | 5.92% | 11.64% | 9.16% |
FCF Yield | 5.14% | 5.66% | 9.82% | -0.12% | 7.90% | -3.07% |
Dividend Yield | 3.21% | 3.58% | 2.63% | 3.26% | 3.17% | 3.62% |
Payout Ratio | 394.69% | - | 134.81% | 51.54% | 24.57% | 35.35% |
Buyback Yield / Dilution | -0.01% | 4.30% | 2.66% | -0.11% | -0.04% | -0.07% |
Total Shareholder Return | 3.19% | 7.89% | 5.30% | 3.15% | 3.13% | 3.55% |